亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Molecular Modeling, Docking, Dynamics and Simulation of Gefitinib and its Derivatives with EGFR in Non-small Cell Lung Cancer

吉非替尼 表皮生长因子受体 表皮生长因子受体抑制剂 肺癌 对接(动物) 癌症研究 虚拟筛选 化学 分子动力学 细胞生长 细胞 药理学 生物化学 受体 肿瘤科 医学 计算化学 护理部
作者
Pulakuntla Swetha Reddy,Kiran Bharat Lokhande,Shuchi Nagar,Vaddi Damodara Reddy,P. Sushma Murthy,K. Venkateswara Swamy
出处
期刊:Current Computer - Aided Drug Design [Bentham Science Publishers]
卷期号:14 (3): 246-252 被引量:31
标识
DOI:10.2174/1573409914666180228111433
摘要

BACKGROUND: Gefitinib (lressa) is the most prescribed drug, highly effective to treat nonsmall cell lung cancer; primarily it was considered that targeted therapy is a kinase inhibitor. The nonsmall cell lung cancer is caused by mutation in the Epithelial Growth Factor Receptor (EGFR) gene. Iressa works by blocking the EGFR protein that helps the cancer cell growth. EGFR protein has lead to the development of anticancer therapeutics directed against EGFR inhibitor including Gefitinib for non-small cell lung cancer. METHODS: To explore the interaction between Gefitinib and its derivatives with crystal structure of EGFR to understand the better molecular insights interaction strategies. Molecular modeling of ligands (Gefitinib and its derivatives) was carried out by Avogadro software till atomic angle stable confirmation was obtained. The partial charges for the ligands were assigned as per standard protocol for molecular docking. All docking simulations were performed with AutoDockVina. Virtual screening was carried out based on binding energy and hydrogen bonding affinity. Molecular dynamics (MD) and Simulation EGFR were done using GROMACS 5.1.1 software to explore the interaction stability in a cell. RESULTS: The stable conformation for EGFR protein trajectories were captured at various time intervals 0-20ns. Few compounds screen based on high affinity as the inhibitor for EGFR may inhibit the cell cycle signaling in non-small cell lung cancer. CONCLUSION: These result suggested a computer-aided screening approach of Gefitinib derivatives with regard to their binding to EGFR for identifying novel drugs for the treatment of non-small cell lung cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Gary发布了新的文献求助10
1秒前
彭于晏的应助被浅呀呀呀采纳,获得10
3秒前
3秒前
extrav发布了新的文献求助10
3秒前
5秒前
6秒前
阳光大山完成签到 ,获得积分10
10秒前
渡增越发布了新的文献求助10
10秒前
11秒前
11秒前
三番完成签到,获得积分10
12秒前
上官若男的应助被extrav采纳,获得10
12秒前
13秒前
碧蓝山灵完成签到,获得积分10
14秒前
h11的应助被美满的水卉采纳,获得30
16秒前
18秒前
19秒前
丘比特的应助被自信的觅风采纳,获得10
20秒前
冷静灵波完成签到 ,获得积分10
24秒前
24秒前
W sir发布了新的文献求助10
25秒前
26秒前
浅呀呀呀发布了新的文献求助10
26秒前
默岩1990完成签到,获得积分10
27秒前
29秒前
乐研客完成签到,获得积分10
30秒前
华仔的应助被科研通管家采纳,获得10
30秒前
null的应助被科研通管家采纳,获得10
30秒前
mmyhn的应助被科研通管家采纳,获得20
30秒前
斯文败类的应助被科研通管家采纳,获得10
31秒前
丘比特的应助被科研通管家采纳,获得10
31秒前
桐桐的应助被科研通管家采纳,获得10
31秒前
31秒前
CodeCraft的应助被科研通管家采纳,获得10
31秒前
31秒前
null的应助被科研通管家采纳,获得10
31秒前
null的应助被科研通管家采纳,获得10
31秒前
肉包子完成签到,获得积分10
32秒前
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158533
求助须知:如何正确求助?哪些是违规求助? 9554333
关于积分的说明 21718908
捐赠科研通 7748056
什么是DOI,文献DOI怎么找? 3427015
关于科研通互助平台的介绍 2551841
邀请新用户注册赠送积分活动 2471242